Litcius/Paper detail

M2-type tumor-associated macrophages upregulated PD-L1 expression in cervical cancer via the PI3K/AKT pathway

Fan Guo, Weina Kong, Dewei Li, Gang Zhao, Miyessar Anwar, Feifei Xia, Yuanming Zhang, Cailing Ma, Xiumin Ma

2024European journal of medical research34 citationsDOIOpen Access PDF

Abstract

BACKGROUND AND PURPOSE: PD-1/PD-L1 inhibitors have become a promising therapy. However, the response rate is lower than 30% in patients with cervical cancer (CC), which is related to immunosuppressive components in tumor microenvironment (TME). Tumor-associated macrophages (TAMs), as one of the most important immune cells, are involved in the formation of tumor suppressive microenvironment. Therefore, it will provide a theoretical basis for curative effect improvement about the regulatory mechanism of TAMs on PD-L1 expression. METHODS: The clinical data and pathological tissues of CC patients were collected, and the expressions of PD-L1, CD68 and CD163 were detected by immunohistochemistry. Bioinformatics was used to analyze the macrophage subtypes involved in PD-L1 regulation. A co-culture model was established to observe the effects of TAMs on the morphology, migration and invasion function of CC cells, and the regulatory mechanism of TAMs on PD-L1. RESULTS: TAMs infiltration. Similarly, PD-L1 expression was associated with M1/M2-type TAMs infiltration in bioinformatics analysis. The results of cell co-culture showed that M1/M2-type TAMs could upregulate PD-L1 expression, especially M2-type TAMs may elevate the PD-L1 expression via PI3K/AKT pathway. Meanwhile, M1/M2-type TAMs can affect the morphological changes, and enhance migration and invasion abilities of CC cells. CONCLUSIONS: TAMs infiltration. In addition, M2-type TAMs can upregulate PD-L1 expression in CC cells through PI3K/AKT pathway, enhance the migration and invasion capabilities, and affect the tumor progression.

Topics & Concepts

CD163Tumor microenvironmentCD68Cancer researchTumor-associated macrophageDownregulation and upregulationPI3K/AKT/mTOR pathwayImmune systemPD-L1ImmunohistochemistryM2 MacrophageMacrophageMedicineChemistryImmunologyBiologyImmunotherapySignal transductionCell biologyIn vitroGeneBiochemistryImmune cells in cancerCancer Immunotherapy and BiomarkersCancer, Hypoxia, and Metabolism